Wealth Enhancement Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.72M Sell
29,592
-9,132
-24% -$1.56M 0.01% 926
2025
Q4
$6.64M Buy
38,724
+3,410
+10% +$554K 0.01% 879
2025
Q3
$5.31M Sell
35,314
-1,847
-5% -$252K 0.01% 922
2025
Q2
$4.83M Sell
37,161
-4,760
-11% -$584K 0.01% 912
2025
Q1
$5.36M Buy
41,921
+1,160
+3% +$157K 0.01% 811
2024
Q4
$5.39M Buy
40,761
+8,342
+26% +$1.17M 0.01% 776
2024
Q3
$4.72M Sell
32,419
-2,643
-8% -$382K 0.01% 744
2024
Q2
$4.81M Sell
35,062
-4,905
-12% -$655K 0.01% 704
2024
Q1
$5.48M Buy
39,967
+2,523
+7% +$345K 0.01% 636
2023
Q4
$5.09M Sell
37,444
-1,587
-4% -$194K 0.01% 608
2023
Q3
$4.77M Buy
+39,031
New +$4.96M 0.02% 593

Other funds holding IBB